Cargando…

HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer

BACKGROUND: Most cancer cells have fundamentally different metabolic characteristics, particularly much higher glycolysis rates than normal tissues, which support the increased demand for biosynthesis and promote tumor progression. We found that transforming growth factor (TGF)-β plays a dual functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yiwei, Chen, Zhencong, Lu, Tao, Bi, Guoshu, Li, Ming, Liang, Jiaqi, Hu, Zhengyang, Zheng, Yuansheng, Yin, Jiacheng, Xi, Junjie, Lin, Zongwu, Zhan, Cheng, Jiang, Wei, Wang, Qun, Tan, Lijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690885/
https://www.ncbi.nlm.nih.gov/pubmed/34930376
http://dx.doi.org/10.1186/s13046-021-02188-y
_version_ 1784618696517353472
author Huang, Yiwei
Chen, Zhencong
Lu, Tao
Bi, Guoshu
Li, Ming
Liang, Jiaqi
Hu, Zhengyang
Zheng, Yuansheng
Yin, Jiacheng
Xi, Junjie
Lin, Zongwu
Zhan, Cheng
Jiang, Wei
Wang, Qun
Tan, Lijie
author_facet Huang, Yiwei
Chen, Zhencong
Lu, Tao
Bi, Guoshu
Li, Ming
Liang, Jiaqi
Hu, Zhengyang
Zheng, Yuansheng
Yin, Jiacheng
Xi, Junjie
Lin, Zongwu
Zhan, Cheng
Jiang, Wei
Wang, Qun
Tan, Lijie
author_sort Huang, Yiwei
collection PubMed
description BACKGROUND: Most cancer cells have fundamentally different metabolic characteristics, particularly much higher glycolysis rates than normal tissues, which support the increased demand for biosynthesis and promote tumor progression. We found that transforming growth factor (TGF)-β plays a dual function in regulating glycolysis and cell proliferation in non-small cell lung cancer. METHODS: We used the PET/MRI imaging system to observe the glucose metabolism of subcutaneous tumors in nude mice. Energy metabolism of non-small cell lung cancer cell lines detected by the Seahorse XFe96 cell outflow analyzer. Co-immunoprecipitation assays were used to detect the binding of Smads and HIF-1α. Western blotting and qRT-PCR were used to detect the regulatory effects of TGF-β and HIF-1α on c-MYC, PKM1/2, and cell cycle-related genes. RESULTS: We discovered that TGF-β could inhibit glycolysis under normoxia while significantly promoting tumor cells’ glycolysis under hypoxia in vitro and in vivo. The binding of hypoxia-inducible factor (HIF)-1α to the MH2 domain of phosphorylated Smad3 switched TGF-β function to glycolysis by changing Smad partners under hypoxia. The Smad-p107-E2F4/5 complex that initially inhibited c-Myc expression was transformed into a Smad-HIF-1α complex that promoted the expression of c-Myc. The increased expression of c-Myc promoted alternative splicing of PKM to PKM2, resulting in the metabolic reprogramming of tumor cells. In addition, the TGF-β/Smad signal lost its effect on cell cycle regulatory protein p15/p21. Furthermore, high expression of c-Myc inhibited p15/p21 and promoted the proliferation of tumor cells under hypoxia. CONCLUSIONS: Our results indicated that HIF-1α functions as a critical factor in the dual role of TGF-β in tumor cells, and may be used as a biomarker or therapeutic target for TGF-β mediated cancer progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02188-y.
format Online
Article
Text
id pubmed-8690885
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86908852021-12-21 HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer Huang, Yiwei Chen, Zhencong Lu, Tao Bi, Guoshu Li, Ming Liang, Jiaqi Hu, Zhengyang Zheng, Yuansheng Yin, Jiacheng Xi, Junjie Lin, Zongwu Zhan, Cheng Jiang, Wei Wang, Qun Tan, Lijie J Exp Clin Cancer Res Research BACKGROUND: Most cancer cells have fundamentally different metabolic characteristics, particularly much higher glycolysis rates than normal tissues, which support the increased demand for biosynthesis and promote tumor progression. We found that transforming growth factor (TGF)-β plays a dual function in regulating glycolysis and cell proliferation in non-small cell lung cancer. METHODS: We used the PET/MRI imaging system to observe the glucose metabolism of subcutaneous tumors in nude mice. Energy metabolism of non-small cell lung cancer cell lines detected by the Seahorse XFe96 cell outflow analyzer. Co-immunoprecipitation assays were used to detect the binding of Smads and HIF-1α. Western blotting and qRT-PCR were used to detect the regulatory effects of TGF-β and HIF-1α on c-MYC, PKM1/2, and cell cycle-related genes. RESULTS: We discovered that TGF-β could inhibit glycolysis under normoxia while significantly promoting tumor cells’ glycolysis under hypoxia in vitro and in vivo. The binding of hypoxia-inducible factor (HIF)-1α to the MH2 domain of phosphorylated Smad3 switched TGF-β function to glycolysis by changing Smad partners under hypoxia. The Smad-p107-E2F4/5 complex that initially inhibited c-Myc expression was transformed into a Smad-HIF-1α complex that promoted the expression of c-Myc. The increased expression of c-Myc promoted alternative splicing of PKM to PKM2, resulting in the metabolic reprogramming of tumor cells. In addition, the TGF-β/Smad signal lost its effect on cell cycle regulatory protein p15/p21. Furthermore, high expression of c-Myc inhibited p15/p21 and promoted the proliferation of tumor cells under hypoxia. CONCLUSIONS: Our results indicated that HIF-1α functions as a critical factor in the dual role of TGF-β in tumor cells, and may be used as a biomarker or therapeutic target for TGF-β mediated cancer progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02188-y. BioMed Central 2021-12-20 /pmc/articles/PMC8690885/ /pubmed/34930376 http://dx.doi.org/10.1186/s13046-021-02188-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Huang, Yiwei
Chen, Zhencong
Lu, Tao
Bi, Guoshu
Li, Ming
Liang, Jiaqi
Hu, Zhengyang
Zheng, Yuansheng
Yin, Jiacheng
Xi, Junjie
Lin, Zongwu
Zhan, Cheng
Jiang, Wei
Wang, Qun
Tan, Lijie
HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer
title HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer
title_full HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer
title_fullStr HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer
title_full_unstemmed HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer
title_short HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer
title_sort hif-1α switches the functionality of tgf-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690885/
https://www.ncbi.nlm.nih.gov/pubmed/34930376
http://dx.doi.org/10.1186/s13046-021-02188-y
work_keys_str_mv AT huangyiwei hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT chenzhencong hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT lutao hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT biguoshu hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT liming hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT liangjiaqi hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT huzhengyang hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT zhengyuansheng hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT yinjiacheng hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT xijunjie hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT linzongwu hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT zhancheng hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT jiangwei hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT wangqun hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer
AT tanlijie hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer